<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">kurskvest</journal-id><journal-title-group><journal-title xml:lang="ru">Человек и его здоровье</journal-title><trans-title-group xml:lang="en"><trans-title>Humans and their health</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1998-5746</issn><issn pub-type="epub">1998-5754</issn><publisher><publisher-name>Kursk State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21626/vestnik/2020-2/08</article-id><article-id custom-type="elpub" pub-id-type="custom">kurskvest-831</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИКО-БИОЛОГИЧЕСКИЕ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MEDICOBIOLOGICAL SCIENCES</subject></subj-group></article-categories><title-group><article-title>Сахарный диабет как следствие нейроиммуноэндокринных нарушений</article-title><trans-title-group xml:lang="en"><trans-title>Diabetes mellitus as a result of neuroimmunoendocrine disorders</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5336-4455</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Самотруева</surname><given-names>Марина Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Samotruyeva</surname><given-names>Marina A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д-р мед. наук, профессор, зав. кафедрой фармакогнозии, фармацевтической технологии и биотехнологии</p></bio><bio xml:lang="en"><p>DM, Professor, Head of Pharmacognosy, Pharmaceutical Technology and Biotechnology Department</p></bio><email xlink:type="simple">ms1506@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9630-2913</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сергалиева</surname><given-names>Мариям Утежановна</given-names></name><name name-style="western" xml:lang="en"><surname>Sergaliyeva</surname><given-names>Mariyam U.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ст. преподаватель кафедры фармакогнозии, фармацевтической технологии и биотехнологии</p></bio><bio xml:lang="en"><p>Senior Lecturer of Pharmacognosy, Pharmaceutical Technology and Biotechnology Department</p></bio><email xlink:type="simple">charlina_astr@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-9994-4751</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Цибизова</surname><given-names>Александра Александровна</given-names></name><name name-style="western" xml:lang="en"><surname>Tsibizova</surname><given-names>Aleksandra A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>ст. преподаватель кафедры фармакогнозии, фармацевтической технологии и биотехнологии</p></bio><bio xml:lang="en"><p>Senior Lecturer of Pharmacognosy, Pharmaceutical Technology and Biotechnology Department</p></bio><email xlink:type="simple">sasha3633@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7899-1666</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ахадова</surname><given-names>Диана Ахматхановна</given-names></name><name name-style="western" xml:lang="en"><surname>Akhadova</surname><given-names>Diana A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>аспирант кафедры фармакогнозии, фармацевтической технологии и биотехнологии</p></bio><email xlink:type="simple">akhadova.dinara@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Астраханский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Astrakhan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>25</day><month>06</month><year>2020</year></pub-date><volume>0</volume><issue>2</issue><fpage>57</fpage><lpage>64</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Самотруева М.А., Сергалиева М.У., Цибизова А.А., Ахадова Д.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Самотруева М.А., Сергалиева М.У., Цибизова А.А., Ахадова Д.А.</copyright-holder><copyright-holder xml:lang="en">Samotruyeva M.A., Sergaliyeva M.U., Tsibizova A.A., Akhadova D.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.kursk-vestnik.ru/jour/article/view/831">https://www.kursk-vestnik.ru/jour/article/view/831</self-uri><abstract><p>В обзорной статье представлен анализ отечественной и зарубежной научной литературы, посвященной изучению нейроиммунных нарушений, приводящих к развитию сахарного диабета. Установлено, что нервная, иммунная и эндокринная системы выступают в качестве регуляторной триады, поддерживающей постоянство организма и дисфункциональные изменения одной из систем, приводят к изменениям в других, что сопровождается запуском различных патологических процессов. Единство регуляторной триады объясняется структурно-функциональными особенностями гипоталамо-гипофизарной системы, дизрегуляция которой может выступать в качестве пускового механизма развития как нервной и эндокринной, так и иммунной патологии, при этом инициальным звеном патологии каждой системы могут быть дизрегуляционные нарушения в других интегративных системах. Так, нарушения со стороны меланокортиновой и дофаминовой сигнальных систем, а также иммуноопосредованая деструкция инсулинпродуцирующих клеток поджелудочной железы способны привести к возникновению диабета. Причиной развития сахарного диабета рассматривается и иммунная патология, сопровождающаяся нарушением цитокиновой регуляции, а именно преобладанием провоспалительных цитокинов, таких как IL-1β, IL-2, TNF-α и др. В свою очередь, сахарный диабет может послужить причиной возникновения нарушений со стороны нервной (нейропатии), иммунной (снижение резистентности организма), кровообращения (ангиопатии), а также и других систем организма. Основываясь на данных Всемирной организации здравоохранения о чрезмерно высоком росте заболеваемости сахарным диабетом, усугубляющимся развитием коморбидных патологий, как следствие, приводящих к инвалидизации населения, необходимо детальное изучение механизмов развития данного заболевания с целью дальнейшего поиска новых средств коррекции патологических состояний.</p></abstract><trans-abstract xml:lang="en"><p>The review article presents an analysis of domestic and foreign scientific literature devoted to the study of neuroimmune disorders leading to the development of diabetes mellitus. It has been established that the nervous, immune and endocrine systems act as a regulatory triad that maintains the constancy of the organism and dysfunctional changes in one of the systems, lead to changes in others, which is accompanied by the launch of various pathological processes. The unity of the regulatory triad is explained by the structural and functional features of the hypothalamic-pituitary system, the dysregulation of which can act as a triggering mechanism for the development of both nervous and endocrine and immune pathologies, while the initial link in the pathology of each system can be dysregulation disorders in other integrative systems. Thus, disturbances in the melanocortin and dopamine signaling systems, as well as immune-mediated destruction of insulin-producing cells in the pancreas, can lead to diabetes. The cause of the development of diabetes mellitus is also considered an immune pathology, accompanied by a violation of cytokine regulation, namely the predominance of pro-inflammatory cytokines, such as IL-1β, IL-2, TNF-α, etc. In turn, diabetes mellitus can cause disorders from the nervous (neuropathy), immune (decreased body resistance), blood circulation (angiopathy), as well as other body systems. Based on the data of the World Health Organization about an excessively high increase in the incidence of diabetes mellitus, the aggravating development of comorbid pathologies, as a result of leading to disability of the population, a detailed study of the mechanisms of the development of this disease is necessary in order to further search for new means of correcting pathological conditions.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>иммунная система</kwd><kwd>нервная система</kwd><kwd>эндокринная система</kwd><kwd>нейроиммуноэндокринология</kwd><kwd>сахарный диабет</kwd></kwd-group><kwd-group xml:lang="en"><kwd>immune system</kwd><kwd>nervous system</kwd><kwd>endocrine system</kwd><kwd>neuroimmunoendocrinology</kwd><kwd>diabetes mellitus</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Alekseev L.P., Dedov I.I., Khaitov R.M., Boldyreva M.N., Trofimov D.Yu., Peterkova V.A., Kuraeva T.L., Abramov D.D. Immunogenetics of type 1 diabetes - from basic research to the clinic. Annals of the Russian academy of medical sciences. 2012;67(1):75-80 (in Russ.). DOI: 10.15690/vramn.v67i1.114</mixed-citation><mixed-citation xml:lang="en">Alekseev L.P., Dedov I.I., Khaitov R.M., Boldyreva M.N., Trofimov D.Yu., Peterkova V.A., Kuraeva T.L., Abramov D.D. Immunogenetics of type 1 diabetes - from basic research to the clinic. Annals of the Russian academy of medical sciences. 2012;67(1):75-80 (in Russ.). DOI: 10.15690/vramn.v67i1.114</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Beloglazov V.A., Kochukova G.N., Alekseeva A.A. The interaction of the main regulatory systems of the body. Crimean journal of internal diseases. 2007;2(2-9):24-30 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Beloglazov V.A., Kochukova G.N., Alekseeva A.A. The interaction of the main regulatory systems of the body. Crimean journal of internal diseases. 2007;2(2-9):24-30 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ivanov V.V., Shakhristova E.V., Stepovaya E.A., Litvyakov N.V., Perekucha N.A., Nosareva O.L., Fedorova T.S., Novitskiy V.V. Oxidative stress in the pathogenesis of type 1 diabetes: the role of adipocyte xanthine oxidase. Bulletin of Siberian Medicine. 2017;16(4):134-143 (in Russ.). DOI: 10.20538/1682-0363-2017-4-134-143</mixed-citation><mixed-citation xml:lang="en">Ivanov V.V., Shakhristova E.V., Stepovaya E.A., Litvyakov N.V., Perekucha N.A., Nosareva O.L., Fedorova T.S., Novitskiy V.V. Oxidative stress in the pathogenesis of type 1 diabetes: the role of adipocyte xanthine oxidase. Bulletin of Siberian Medicine. 2017;16(4):134-143 (in Russ.). DOI: 10.20538/1682-0363-2017-4-134-143</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kryzhanovsky G.N. Disregulatory pathology. Pathological physiology and experimental therapy. 2002;3:1-29 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Kryzhanovsky G.N. Disregulatory pathology. Pathological physiology and experimental therapy. 2002;3:1-29 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kryzhanovsky G.N., Magaeva S.V. Pathophysiology of neuroimmune interactions. Patogenez. 2010;8(1):4-9 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Kryzhanovsky G.N., Magaeva S.V. Pathophysiology of neuroimmune interactions. Patogenez. 2010;8(1):4-9 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kuznetsov E.V., Zhukova L.A., Pakhomova E.A., Gulamov A.A. Endocrine deseases as medical-social prolem of today. Sovremennye problemy nauki i obrazovaniya. 2017;4:62 (in Russ.). URL: http://science-education.ru/ru/article/view?id=26662</mixed-citation><mixed-citation xml:lang="en">Kuznetsov E.V., Zhukova L.A., Pakhomova E.A., Gulamov A.A. Endocrine deseases as medical-social prolem of today. Sovremennye problemy nauki i obrazovaniya. 2017;4:62 (in Russ.). URL: http://science-education.ru/ru/article/view?id=26662</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kurumchina O.B., Shnayder N.A., Petrova M.M., Kirichkova G.A. Genetic aspects of diabetes mellitus. Bulletin of Novosibirsk State University. Series: Biology, Clinical Medicine. 2009;7(1):129-135 (in Russ.)</mixed-citation><mixed-citation xml:lang="en">Kurumchina O.B., Shnayder N.A., Petrova M.M., Kirichkova G.A. Genetic aspects of diabetes mellitus. Bulletin of Novosibirsk State University. Series: Biology, Clinical Medicine. 2009;7(1):129-135 (in Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Mazur L.P. State of the α-factor system of tumor necrosis in type 1 and type 2 diabetes. Vestnik problem biologii i meditsiny. 2014;1-4 (113):156-160 (in Ukr.).</mixed-citation><mixed-citation xml:lang="en">Mazur L.P. State of the α-factor system of tumor necrosis in type 1 and type 2 diabetes. Vestnik problem biologii i meditsiny. 2014;1-4 (113):156-160 (in Ukr.).</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Parakhonsky A.P. neuroimmune endocrine interactions to the regulation of homeostasis. Modern high technologies. 2007;8:45-47 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Parakhonsky A.P. neuroimmune endocrine interactions to the regulation of homeostasis. Modern high technologies. 2007;8:45-47 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Parakhonsky A.P., Tsyganok S.S. Basic principles of correction of dysregulatory pathology. Advances in current natural sciences. 2003;12:60-61 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Parakhonsky A.P., Tsyganok S.S. Basic principles of correction of dysregulatory pathology. Advances in current natural sciences. 2003;12:60-61 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Prokhorenko T.S., Saprina T.V., Lazarenko F.E., Ryazantseva N.V., Vorozhtsova I.N., Novitsky V.V. System of tumor necrosis factor α in the pathogenesis of autoimmune diabetes mellitus. Bulletin of Siberian Medicine. 2011;10(1):64-69 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Prokhorenko T.S., Saprina T.V., Lazarenko F.E., Ryazantseva N.V., Vorozhtsova I.N., Novitsky V.V. System of tumor necrosis factor α in the pathogenesis of autoimmune diabetes mellitus. Bulletin of Siberian Medicine. 2011;10(1):64-69 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ryzhkov P.A., Ryzhkova N.S., Konovalova R.V. Genetics of type I diabetes. Zhivye biokosnye sist. 2013;4:14 (in Russ.). URL: http://jbks.ru/archive/issue-4/article-14</mixed-citation><mixed-citation xml:lang="en">Ryzhkov P.A., Ryzhkova N.S., Konovalova R.V. Genetics of type I diabetes. Zhivye biokosnye sist. 2013;4:14 (in Russ.). URL: http://jbks.ru/archive/issue-4/article-14</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Tatarkin A.A., tatarkina N.D., Andryukov B.G. Neuroimmunoendocrine interactions in the system of intercellular functional multilevel regulation of homeostasis. Health. Medical ecology. Science. 2010;3(43):13-17 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Tatarkin A.A., tatarkina N.D., Andryukov B.G. Neuroimmunoendocrine interactions in the system of intercellular functional multilevel regulation of homeostasis. Health. Medical ecology. Science. 2010;3(43):13-17 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Farkhutdinov I.M., Farkhutdinova L.M. Geoecological aspects of type 2 diabetes mellitus. Bulletin of the Academy of Sciences. 2016;21(3-83):31 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Farkhutdinov I.M., Farkhutdinova L.M. Geoecological aspects of type 2 diabetes mellitus. Bulletin of the Academy of Sciences. 2016;21(3-83):31 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Shapovalyants O.S., Nikonova T.V. Diagnostic and prognostic value of autoantibodies for diabetes mellitus. a novel T1D autoimmunity target - zinc transporter 8 (ZNT8). Sakharnyy diabet. 2011;2:18-21 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Shapovalyants O.S., Nikonova T.V. Diagnostic and prognostic value of autoantibodies for diabetes mellitus. a novel T1D autoimmunity target - zinc transporter 8 (ZNT8). Sakharnyy diabet. 2011;2:18-21 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov A.O. Functional activity of the brain insulin signaling sys tem in norm and in type 2 diabetes mellitus. Russian journal of physiology. 2015;101(10):1103-1127 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Shpakov A.O. Functional activity of the brain insulin signaling sys tem in norm and in type 2 diabetes mellitus. Russian journal of physiology. 2015;101(10):1103-1127 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov A.O., Derkach K.V. Melanocortin signaling system of the hypothalamus and its functional state in the conditions of type 2 diabetes mellitus and metabolic syndrome. Russian journal of physiology. 2016;102(1):18-40 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Shpakov A.O., Derkach K.V. Melanocortin signaling system of the hypothalamus and its functional state in the conditions of type 2 diabetes mellitus and metabolic syndrome. Russian journal of physiology. 2016;102(1):18-40 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov A.O., Derkach K.V. The brain peptidergic signaling systems in diabetes mellitus. Cell and tissue biology. 2013;7(3):212-220. DOI: 10.1134/S1990519X13030115</mixed-citation><mixed-citation xml:lang="en">Shpakov A.O., Derkach K.V. The brain peptidergic signaling systems in diabetes mellitus. Cell and tissue biology. 2013;7(3):212-220. DOI: 10.1134/S1990519X13030115</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shpakov A.O., Derkach K.V., Sukhov I.B. Dopamine signaling system of the brain in type 2 diabetes and metabolic syndrome. Tsitologiya. 2016;58(3):167-177 (in Russ.).</mixed-citation><mixed-citation xml:lang="en">Shpakov A.O., Derkach K.V., Sukhov I.B. Dopamine signaling system of the brain in type 2 diabetes and metabolic syndrome. Tsitologiya. 2016;58(3):167-177 (in Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Afrisham R., Paknejad M., Soliemanifar O., Sadegh-Nejadi S., Meshkani R., Ashtary-Larky D. The Influence of Psychological Stress on the Initiation and Progression of Diabetes and Cancer. Int J Endocrinol Metab. 2019;17(2):e67400. DOI: 10.5812/ijem.67400</mixed-citation><mixed-citation xml:lang="en">Afrisham R., Paknejad M., Soliemanifar O., Sadegh-Nejadi S., Meshkani R., Ashtary-Larky D. The Influence of Psychological Stress on the Initiation and Progression of Diabetes and Cancer. Int J Endocrinol Metab. 2019;17(2):e67400. DOI: 10.5812/ijem.67400</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Akmaev I.G. Neuroimmunoendocrine interactions: their role in dysregulatory pathologies. Patol Fiziol Eksp Ter. 2001;(4):3-10</mixed-citation><mixed-citation xml:lang="en">Akmaev I.G. Neuroimmunoendocrine interactions: their role in dysregulatory pathologies. Patol Fiziol Eksp Ter. 2001;(4):3-10</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Anders A.F.S. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279-293. DOI: 10.1007/s00592-010-0218-0</mixed-citation><mixed-citation xml:lang="en">Anders A.F.S. Encephalopathies: the emerging diabetic complications. Acta Diabetol. 2010;47(4):279-293. DOI: 10.1007/s00592-010-0218-0</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Andersen M.K., Hansen T. Genetic Aspects of Latent Autoimmune Diabetes in Adults: A Mini-Review. Curr Diabetes Rev. 2019;15(3):194-198. DOI: 10.2174/1573399814666180730123226</mixed-citation><mixed-citation xml:lang="en">Andersen M.K., Hansen T. Genetic Aspects of Latent Autoimmune Diabetes in Adults: A Mini-Review. Curr Diabetes Rev. 2019;15(3):194-198. DOI: 10.2174/1573399814666180730123226</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Aslan I.R., Ranadive S.A., Valle I., Kollipara S., Noble J.A., Vaisse C. The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus. Int J Obes (Lond). 2014;38(1):148-51. DOI: 10.1038/ijo.2013.53</mixed-citation><mixed-citation xml:lang="en">Aslan I.R., Ranadive S.A., Valle I., Kollipara S., Noble J.A., Vaisse C. The melanocortin system and insulin resistance in humans: insights from a patient with complete POMC deficiency and type 1 diabetes mellitus. Int J Obes (Lond). 2014;38(1):148-51. DOI: 10.1038/ijo.2013.53</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Assar M.E., Angulo J., Rodríguez-Mañas L. Diabetes and ageing-induced vascular inflammation. J Physiol. 2016;594(8):2125-2146. DOI: 10.1113/JP270841</mixed-citation><mixed-citation xml:lang="en">Assar M.E., Angulo J., Rodríguez-Mañas L. Diabetes and ageing-induced vascular inflammation. J Physiol. 2016;594(8):2125-2146. DOI: 10.1113/JP270841</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Bakshi D., Kaur G., Singh D., Sahota J., Thakur A., Grover S. Estimation of Plasma Levels of Tumor Necrosis Factor-a, Interleukin-4 and 6 in Patients with Chronic Periodontitis and Type II Diabetes Mellitus. J Contemp Dent Pract. 2018;19(2):166-169. DOI: 10.5005/jp-journals-10024-2231</mixed-citation><mixed-citation xml:lang="en">Bakshi D., Kaur G., Singh D., Sahota J., Thakur A., Grover S. Estimation of Plasma Levels of Tumor Necrosis Factor-a, Interleukin-4 and 6 in Patients with Chronic Periodontitis and Type II Diabetes Mellitus. J Contemp Dent Pract. 2018;19(2):166-169. DOI: 10.5005/jp-journals-10024-2231</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Berchtold L.A., Prause M., Stоrling J., Mandrup-Poulsen T. Cytokines and pancreatic β-cell apoptosis. Adv Clin Chem. 2016;75:99-158. DOI: 10.1016/bs.acc.2016.02.001</mixed-citation><mixed-citation xml:lang="en">Berchtold L.A., Prause M., Stоrling J., Mandrup-Poulsen T. Cytokines and pancreatic β-cell apoptosis. Adv Clin Chem. 2016;75:99-158. DOI: 10.1016/bs.acc.2016.02.001</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Calderon B., Unanue E.R. Antigen presentation events in autoimmune diabetes. Curr Opin Immunol. 2012;24(1):119-128. DOI: 10.1016/j.coi.2011.11.005</mixed-citation><mixed-citation xml:lang="en">Calderon B., Unanue E.R. Antigen presentation events in autoimmune diabetes. Curr Opin Immunol. 2012;24(1):119-128. DOI: 10.1016/j.coi.2011.11.005</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Chiloiro S., De Marinis L. Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis. Eur J Endocrinol. 2018;178(2):L1. DOI: 10.1530/EJE-17-0910</mixed-citation><mixed-citation xml:lang="en">Chiloiro S., De Marinis L. Diabetes insipidus is an unfavorable prognostic factor for response to glucocorticoids in patients with autoimmune hypophysitis. Eur J Endocrinol. 2018;178(2):L1. DOI: 10.1530/EJE-17-0910</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Cuschieri S. The genetic side of type 2 diabetes - A review. Diabetes Metab Syndr. 2019;13(4):2503-2506. DOI: 10.1016/j.dsx.2019.07.012</mixed-citation><mixed-citation xml:lang="en">Cuschieri S. The genetic side of type 2 diabetes - A review. Diabetes Metab Syndr. 2019;13(4):2503-2506. DOI: 10.1016/j.dsx.2019.07.012</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Donath M.Y., Dinarello C.A., Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019;19(12):734-746. DOI: 10.1038/s41577-019-0213-9</mixed-citation><mixed-citation xml:lang="en">Donath M.Y., Dinarello C.A., Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019;19(12):734-746. DOI: 10.1038/s41577-019-0213-9</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Feldman E.L., Callaghan B.C., Pop-Busui R., Zochodne D.W., Wright D.E., Bennett D.L., Bril V., Russell J.W., et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;13;5(1):42. DOI: 10.1038/s41572-019-0097-9</mixed-citation><mixed-citation xml:lang="en">Feldman E.L., Callaghan B.C., Pop-Busui R., Zochodne D.W., Wright D.E., Bennett D.L., Bril V., Russell J.W., et al. Diabetic neuropathy. Nat Rev Dis Primers. 2019;13;5(1):42. DOI: 10.1038/s41572-019-0097-9</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Fève B., Bastard J.P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5(6):305-311. DOI: 10.1038/nrendo.2009.62</mixed-citation><mixed-citation xml:lang="en">Fève B., Bastard J.P. The role of interleukins in insulin resistance and type 2 diabetes mellitus. Nat Rev Endocrinol. 2009;5(6):305-311. DOI: 10.1038/nrendo.2009.62</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Fiory F., Perruolo G., Cimmino I., Cabaro S., Pignalosa F.C., Miele C., Beguinot F., Formisano P., et al. The Relevance of Insulin Action in the Dopaminergic System. Front Neurosci. 2019;13:868. DOI: 10.3389/fnins.2019.00868</mixed-citation><mixed-citation xml:lang="en">Fiory F., Perruolo G., Cimmino I., Cabaro S., Pignalosa F.C., Miele C., Beguinot F., Formisano P., et al. The Relevance of Insulin Action in the Dopaminergic System. Front Neurosci. 2019;13:868. DOI: 10.3389/fnins.2019.00868</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Frisbee J.C. Obesity, insulin resistance, and microvascular adaptation. Microcirculation. 2017;24(2). DOI: 10.1111/micc.12346</mixed-citation><mixed-citation xml:lang="en">Frisbee J.C. Obesity, insulin resistance, and microvascular adaptation. Microcirculation. 2017;24(2). DOI: 10.1111/micc.12346</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Girardet C., Butler A.A. Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta. 2014;1842(3):482-494. DOI: 10.1016/j.bbadis.2013.05.004</mixed-citation><mixed-citation xml:lang="en">Girardet C., Butler A.A. Neural melanocortin receptors in obesity and related metabolic disorders. Biochim Biophys Acta. 2014;1842(3):482-494. DOI: 10.1016/j.bbadis.2013.05.004</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Goligorsky M.S. Vascular endothelium in diabetes. Am J Physiol Renal Physiol. 2017;312(2):F266-F275. DOI: 10.1152/ajprenal.00473.2016</mixed-citation><mixed-citation xml:lang="en">Goligorsky M.S. Vascular endothelium in diabetes. Am J Physiol Renal Physiol. 2017;312(2):F266-F275. DOI: 10.1152/ajprenal.00473.2016</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Hardt P.D, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res. 2011;2011:761950. DOI: 10.1155/2011/761950</mixed-citation><mixed-citation xml:lang="en">Hardt P.D, Ewald N. Exocrine pancreatic insufficiency in diabetes mellitus: a complication of diabetic neuropathy or a different type of diabetes? Exp Diabetes Res. 2011;2011:761950. DOI: 10.1155/2011/761950</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Herder C., Carstensen M., Ouwens D.M. Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab. 2013;15 Suppl 3:39-50. DOI: 10.1111/dom.12155</mixed-citation><mixed-citation xml:lang="en">Herder C., Carstensen M., Ouwens D.M. Anti-inflammatory cytokines and risk of type 2 diabetes. Diabetes Obes Metab. 2013;15 Suppl 3:39-50. DOI: 10.1111/dom.12155</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Howson J.M., Walker N.M., Clayton D., Todd J.A. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab. 2009;11 Suppl 1(Suppl 1):31-45. DOI: 10.1111/j.1463-1326.2008.01001.x</mixed-citation><mixed-citation xml:lang="en">Howson J.M., Walker N.M., Clayton D., Todd J.A. Confirmation of HLA class II independent type 1 diabetes associations in the major histocompatibility complex including HLA-B and HLA-A. Diabetes Obes Metab. 2009;11 Suppl 1(Suppl 1):31-45. DOI: 10.1111/j.1463-1326.2008.01001.x</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Kakleas K., Soldatou A., Karachaliou F., Karavanaki K. Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmun Rev. 2015;14(9):781-797. DOI: 10.1016/j.autrev.2015.05.002</mixed-citation><mixed-citation xml:lang="en">Kakleas K., Soldatou A., Karachaliou F., Karavanaki K. Associated autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1DM). Autoimmun Rev. 2015;14(9):781-797. DOI: 10.1016/j.autrev.2015.05.002</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Karayannis G., Giamouzis G., Cokkinos D., Skoularigis J., Triposkiadis F. Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther. 2012;10(6):747-765. DOI: 10.1586/erc.12.53</mixed-citation><mixed-citation xml:lang="en">Karayannis G., Giamouzis G., Cokkinos D., Skoularigis J., Triposkiadis F. Diabetic cardiovascular autonomic neuropathy: clinical implications. Expert Rev Cardiovasc Ther. 2012;10(6):747-765. DOI: 10.1586/erc.12.53</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Kibel A., Selthofer-Relatic K., Drenjancevic I., Bacun T., Bosnjak I., Kibel D., Gros M. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res. 2017;45(6):1901-1929. DOI: 10.1177/0300060516675504</mixed-citation><mixed-citation xml:lang="en">Kibel A., Selthofer-Relatic K., Drenjancevic I., Bacun T., Bosnjak I., Kibel D., Gros M. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res. 2017;45(6):1901-1929. DOI: 10.1177/0300060516675504</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">King G.L. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8 Suppl):1527-1534. DOI: 10.1902/jop.2008.080246</mixed-citation><mixed-citation xml:lang="en">King G.L. The role of inflammatory cytokines in diabetes and its complications. J Periodontol. 2008;79(8 Suppl):1527-1534. DOI: 10.1902/jop.2008.080246</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Langenberg C., Lotta L.A. Genomic insights into the causes of type 2 diabetes. Lancet. 2018;391(10138):2463-2474. DOI: 10.1016/S0140-6736(18)31132-2</mixed-citation><mixed-citation xml:lang="en">Langenberg C., Lotta L.A. Genomic insights into the causes of type 2 diabetes. Lancet. 2018;391(10138):2463-2474. DOI: 10.1016/S0140-6736(18)31132-2</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Laugesen E., Оstergaard J.A., Leslie R.D, Danish Diabetes Academy Workshop and Workshop Speakers. Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015; l-32(7):843-852. DOI: 10.1111/dme.12700</mixed-citation><mixed-citation xml:lang="en">Laugesen E., Оstergaard J.A., Leslie R.D, Danish Diabetes Academy Workshop and Workshop Speakers. Latent autoimmune diabetes of the adult: current knowledge and uncertainty. Diabet Med. 2015; l-32(7):843-852. DOI: 10.1111/dme.12700</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Lindner J.R. Cause or Effect? Microvascular Dysfunction in Insulin-Resistant States. Circ Cardiovasc Imaging. 2018;11(4):e007725 DOI: 10.1161/CIRCIMAGING.118.007725</mixed-citation><mixed-citation xml:lang="en">Lindner J.R. Cause or Effect? Microvascular Dysfunction in Insulin-Resistant States. Circ Cardiovasc Imaging. 2018;11(4):e007725 DOI: 10.1161/CIRCIMAGING.118.007725</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Maiese K. New Insights for Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2015;2015:875961. DOI: 10.1155/2015/875961</mixed-citation><mixed-citation xml:lang="en">Maiese K. New Insights for Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2015;2015:875961. DOI: 10.1155/2015/875961</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Mandrup-Poulsen T., Pickersgill L., Donath M.Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol. 2010;6(3):158-166. DOI: 10.1038/nrendo.2009.271</mixed-citation><mixed-citation xml:lang="en">Mandrup-Poulsen T., Pickersgill L., Donath M.Y. Blockade of interleukin 1 in type 1 diabetes mellitus. Nat Rev Endocrinol. 2010;6(3):158-166. DOI: 10.1038/nrendo.2009.271</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Meek T.H., Matsen M.E., Damian V., Cubelo A., Chua S.C. Jr., Morton G.J. Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes. Endocrinology. 2014;155(11):4157-4167. DOI: 10.1210/en.2014-1169</mixed-citation><mixed-citation xml:lang="en">Meek T.H., Matsen M.E., Damian V., Cubelo A., Chua S.C. Jr., Morton G.J. Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes. Endocrinology. 2014;155(11):4157-4167. DOI: 10.1210/en.2014-1169</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Mizisin A.P. Mechanisms of diabetic neuropathy: Schwann cells. Handb Clin Neurol. 2014;126:401-428. DOI: 10.1016/B978-0-444-53480-4.00029-1</mixed-citation><mixed-citation xml:lang="en">Mizisin A.P. Mechanisms of diabetic neuropathy: Schwann cells. Handb Clin Neurol. 2014;126:401-428. DOI: 10.1016/B978-0-444-53480-4.00029-1</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Nederstigt C., Uitbeijerse B.S., Janssen L.G.M., Corssmit E.P.M., de Koning E.J.P., Dekkers O.M. Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol. 2019;180(2):135-144. DOI: 10.1530/EJE-18-0515</mixed-citation><mixed-citation xml:lang="en">Nederstigt C., Uitbeijerse B.S., Janssen L.G.M., Corssmit E.P.M., de Koning E.J.P., Dekkers O.M. Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol. 2019;180(2):135-144. DOI: 10.1530/EJE-18-0515</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Nokoff N., Rewers M. Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci. 2013;1281(1):1-15. DOI: 10.1111/nyas.12021</mixed-citation><mixed-citation xml:lang="en">Nokoff N., Rewers M. Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Ann N Y Acad Sci. 2013;1281(1):1-15. DOI: 10.1111/nyas.12021</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Sadosky A., Schaefer C., Mann R., Bergstrom F., Baik R., Parsons B., Nalamachu S., Nieshoff E., et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the UC: results of retrospective charts review and cross-sectional survey. Diabetes Metab Syndr Obes. 2013;6:79-92. DOI: 10.2147/DMSO.S37415</mixed-citation><mixed-citation xml:lang="en">Sadosky A., Schaefer C., Mann R., Bergstrom F., Baik R., Parsons B., Nalamachu S., Nieshoff E., et al. Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the UC: results of retrospective charts review and cross-sectional survey. Diabetes Metab Syndr Obes. 2013;6:79-92. DOI: 10.2147/DMSO.S37415</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Saxena M., Srivastava N., Banerjee M. Cytokine Gene Variants as Predictors of Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2018;14(3):307-319. DOI: 10.2174/1573399813666170112145429</mixed-citation><mixed-citation xml:lang="en">Saxena M., Srivastava N., Banerjee M. Cytokine Gene Variants as Predictors of Type 2 Diabetes Mellitus. Curr Diabetes Rev. 2018;14(3):307-319. DOI: 10.2174/1573399813666170112145429</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Strain W.D., Paldánius P.M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. DOI: 10.1186/s12933-018-0703-2</mixed-citation><mixed-citation xml:lang="en">Strain W.D., Paldánius P.M. Diabetes, cardiovascular disease and the microcirculation. Cardiovasc Diabetol. 2018;17(1):57. DOI: 10.1186/s12933-018-0703-2</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Valdes A.M., Erlich H.A., Noble J.A. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol. 2005;66:301-313. DOI: 10.1016/j.humimm.2004.12.001</mixed-citation><mixed-citation xml:lang="en">Valdes A.M., Erlich H.A., Noble J.A. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol. 2005;66:301-313. DOI: 10.1016/j.humimm.2004.12.001</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Vinik A.I., Nevoret M.L., Casellini C., Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747-787. DOI: 10.1016/j.ecl.2013.06.001</mixed-citation><mixed-citation xml:lang="en">Vinik A.I., Nevoret M.L., Casellini C., Parson H. Diabetic neuropathy. Endocrinol Metab Clin North Am. 2013;42(4):747-787. DOI: 10.1016/j.ecl.2013.06.001</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Volmer-Thole M., Lobmann R. Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci. 2016;10;17(6):917. DOI: 10.3390/ijms17060917</mixed-citation><mixed-citation xml:lang="en">Volmer-Thole M., Lobmann R. Neuropathy and Diabetic Foot Syndrome. Int J Mol Sci. 2016;10;17(6):917. DOI: 10.3390/ijms17060917</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao J., Li J., Cai L., Chakrabarti S., Li X. Cytokines and diabetes research. J Diabetes Res. 2014;2014:920613. DOI: 10.1155/2014/920613</mixed-citation><mixed-citation xml:lang="en">Xiao J., Li J., Cai L., Chakrabarti S., Li X. Cytokines and diabetes research. J Diabetes Res. 2014;2014:920613. DOI: 10.1155/2014/920613</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Zakin E., Abrams R., Simpson D.M. Diabetic Neuropathy. Semin Neurol. 2019;39(5):560-569. DOI: 10.1055/s-0039-1688978</mixed-citation><mixed-citation xml:lang="en">Zakin E., Abrams R., Simpson D.M. Diabetic Neuropathy. Semin Neurol. 2019;39(5):560-569. DOI: 10.1055/s-0039-1688978</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Ziegler D., Papanas N., Vinik A.I., Shaw J.E. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb Clin Neurol. 2014;126:3-22. DOI: 10.1016/B978-0-444-53480-4.00001-1</mixed-citation><mixed-citation xml:lang="en">Ziegler D., Papanas N., Vinik A.I., Shaw J.E. Epidemiology of polyneuropathy in diabetes and prediabetes. Handb Clin Neurol. 2014;126:3-22. DOI: 10.1016/B978-0-444-53480-4.00001-1</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
